The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services has 3 clinical trials on record, with 2 currently active. Their work covers Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms.
The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.